Vazyme(SH:688105) Xin Lang Zheng Quan·2025-12-03 02:22Core Points - The stock price of NuoVivian has decreased by 2.07% to 21.76 CNY per share, with a total market capitalization of 8.655 billion CNY [1] - The company has experienced a year-to-date stock price decline of 1.18%, with a 4.27% drop over the last five trading days [1] - NuoVivian's main business includes the research and development of functional proteins and high molecular organic materials, with a revenue composition of 81.86% from biological reagents [1] Financial Performance - As of September 30, NuoVivian reported a total of 9,447 shareholders, an increase of 9.90% from the previous period [2] - For the period from January to September 2025, the company achieved a revenue of 952 million CNY, a year-on-year decrease of 3.40% [2] - The net profit attributable to the parent company was 6.6152 million CNY, reflecting a significant year-on-year decrease of 63.57% [2] Dividend Information - Since its A-share listing, NuoVivian has distributed a total of 731 million CNY in dividends, with 611 million CNY distributed over the past three years [3]